KEGG   DRUG: Eladocagene exuparvovec
Entry
D12407                      Drug                                   
Name
Eladocagene exuparvovec (USAN/INN);
Upstaza (TN)
Remark
ATC code: A16AB26
Efficacy
Nervous system disease agent
  Type
Gene therapy product
Comment
Recombinant AAV2 vector containing the human cDNA for the DDC geneTreatment of AADC deficiency
Target
DDC* [HSA_VAR:1644v1] [HSA:1644] [KO:K01593]
  Pathway
hsa00350  Tyrosine metabolism
hsa00380  Tryptophan metabolism
  Network
nt06028  Dopamine and serotonin metabolism
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AB Enzymes
     A16AB26 Eladocagene exuparvovec
      D12407  Eladocagene exuparvovec (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Enzymes
  Lyases (EC4)
   Carboxy-lyases
    DDC* [HSA_VAR:1644v1]
     D12407  Eladocagene exuparvovec (USAN/INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D12407
 Cellular and gene therapy products
  D12407
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12407
Pharmacogenomic biomarkers [br08341.html]
 Germline mutations in genetic disorder treatments
  D12407
Other DBs
CAS: 2098615-91-7
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system